% alzhub.org library filter
% Source: https://alzhub.org/research?institution=I4387153818
% 25 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{ashton2024-38252443,
  author  = {Ashton, N. J. and Brum, W. S. and Di Molfetta, G. and Benedet, A. L. and Arslan, B. and Jonaitis, E. and Langhough, R. E. and Cody, K. and Wilson, R. and Carlsson, C. M. and Vanmechelen, E. and Montoliu-Gaya, L. and others},
  title   = {{Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology}},
  journal = {JAMA Neurology},
  year    = {2024},
  doi     = {10.1001/jamaneurol.2023.5319},
  pmid    = {38252443},
  url     = {https://doi.org/10.1001/jamaneurol.2023.5319}
}

@article{ashton2021-33585983,
  author  = {Ashton, N. J. and Pascoal, T. A. and Karikari, T. K. and Benedet, A. L. and Lantero-Rodriguez, J. and Brinkmalm, G. and Snellman, A. and others},
  title   = {{Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology}},
  journal = {Acta neuropathologica},
  year    = {2021},
  doi     = {10.1007/s00401-021-02275-6},
  pmid    = {33585983},
  url     = {https://doi.org/10.1007/s00401-021-02275-6}
}

@article{janelidze2023-36087307,
  author  = {Janelidze, S. and Bali, D. and Ashton, N. J. and Barthélemy, N. R. and Vanbrabant, J. and Stoops, E. and Vanmechelen, E. and others},
  title   = {{Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2023},
  doi     = {10.1093/brain/awac333},
  pmid    = {36087307},
  url     = {https://doi.org/10.1093/brain/awac333}
}

@article{sutphen2015-26147946,
  author  = {Sutphen, C. L. and Jasielec, M. S. and Shah, A. R. and Macy, E. M. and Xiong, C. and Vlassenko, A. G. and Benzinger, T. L. and Stoops, E. E. and others},
  title   = {{Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2015.1285},
  pmid    = {26147946},
  url     = {https://doi.org/10.1001/jamaneurol.2015.1285}
}

@article{mielke2021-34309632,
  author  = {Mielke, M. M. and Frank, R. D. and Dage, J. L. and Jeromin, A. and Ashton, N. J. and Blennow, K. and Karikari, T. K. and Vanmechelen, E. and others},
  title   = {{Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes}},
  journal = {JAMA neurology},
  year    = {2021},
  doi     = {10.1001/jamaneurol.2021.2293},
  pmid    = {34309632},
  url     = {https://doi.org/10.1001/jamaneurol.2021.2293}
}

@article{hilal2017-28984600,
  author  = {Hilal, S. and Akoudad, S. and van Duijn, C. M. and Niessen, W. J. and Verbeek, M. M. and Vanderstichele, H. and Stoops, E. and Ikram, M. A. and others},
  title   = {{Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2017},
  doi     = {10.3233/jad-170458},
  pmid    = {28984600},
  url     = {https://doi.org/10.3233/jad-170458}
}

@article{kovacech2024-39580468,
  author  = {Kovacech, B. and Cullen, N. C. and Novak, P. and Hanes, J. and Kontsekova, E. and Katina, S. and Parrak, V. and Fresser, M. and others},
  title   = {{Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01620-7},
  pmid    = {39580468},
  url     = {https://doi.org/10.1186/s13195-024-01620-7}
}

@article{tijms2024-38195725,
  author  = {Tijms, B. M. and Vromen, E. M. and Mjaavatten, O. and Holstege, H. and Reus, L. M. and van der Lee, S. and Wesenhagen, K. E. J. and Lorenzini, L. and others},
  title   = {{Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles}},
  journal = {Nature aging},
  year    = {2024},
  doi     = {10.1038/s43587-023-00550-7},
  pmid    = {38195725},
  url     = {https://doi.org/10.1038/s43587-023-00550-7}
}

@article{ashton2022-36456833,
  author  = {Ashton, Nicholas James and Janelidze, Shorena and Mattsson, Niklas and Binette, Alexa Pichet and Strandberg, Olof T. and Brum, Wagner Scheeren and Karikari, Thomas K. and González‐Ortiz, Fernando and Di Molfetta, Guglielmo and Meda, Francisco J. and Jonaitis, Erin McMullen and Koscik, Rebecca L. and Cody, Karly Alex and Betthauser, Tobey J. and Li, Yan and Vanmechelen, Eugeen and Palmqvist, Sebastian and Stomrud, Erik and Bateman, Randall John and Zetterberg, Henrik and Johnson, Sterling C. and Blennow, Kaj and Hansson, Oskar},
  title   = {{Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring}},
  journal = {Nature Medicine},
  year    = {2022},
  doi     = {10.1038/s41591-022-02074-w},
  pmid    = {36456833},
  url     = {https://doi.org/10.1038/s41591-022-02074-w}
}

@article{milaaloma2022-35953717,
  author  = {Milà-Alomà, M. and Ashton, N. J. and Shekari, M. and Salvadó, G. and Ortiz-Romero, P. and Montoliu-Gaya, L. and Benedet, A. L. and Karikari, T. K. and others},
  title   = {{Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease}},
  journal = {Nature medicine},
  year    = {2022},
  doi     = {10.1038/s41591-022-01925-w},
  pmid    = {35953717},
  url     = {https://doi.org/10.1038/s41591-022-01925-w}
}

@article{honey2026-41986736,
  author  = {Honey, Madison I. J. and Hok-A-Hin, Yanaika Sylvana and Thijssen, Elisabeth H. and Cousins, Katheryn A Q and van der Weijden, Babette and Veld, Lisanne in ‘t and Stoops, Erik and de Boer, Sterre C.M. and others},
  title   = {{An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration}},
  journal = {Nature Medicine},
  year    = {2026},
  doi     = {10.1038/s41591-026-04341-6},
  pmid    = {41986736},
  url     = {https://doi.org/10.1038/s41591-026-04341-6}
}

@article{leuzy2021-34493616,
  author  = {Leuzy, A. and Janelidze, S. and Mattsson-Carlgren, N. and Palmqvist, S. and Jacobs, D. and Cicognola, C. and Stomrud, E. and Vanmechelen, E. and others},
  title   = {{Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays}},
  journal = {Neurology},
  year    = {2021},
  doi     = {10.1212/wnl.0000000000012727},
  pmid    = {34493616},
  url     = {https://doi.org/10.1212/wnl.0000000000012727}
}

@article{janelidze2016-27042676,
  author  = {Janelidze, S. and Zetterberg, H. and Mattsson, N. and Palmqvist, S. and Vanderstichele, H. and Lindberg, O. and van Westen, D. and Stomrud, E. and others},
  title   = {{CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease}},
  journal = {Annals of clinical and translational neurology},
  year    = {2016},
  doi     = {10.1002/acn3.274},
  pmid    = {27042676},
  url     = {https://doi.org/10.1002/acn3.274}
}

@article{hilal2018-30355213,
  author  = {Hilal, S. and Ikram, M. A. and Verbeek, M. M. and Franco, O. H. and Stoops, E. and Vanderstichele, H. and Niessen, W. J. and Vernooij, M. W.},
  title   = {{C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction With Magnetic Resonance Imaging Markers}},
  journal = {Stroke},
  year    = {2018},
  doi     = {10.1161/strokeaha.118.022317},
  pmid    = {30355213},
  url     = {https://doi.org/10.1161/strokeaha.118.022317}
}

@article{suarezcalvet2020-33169916,
  author  = {Suárez-Calvet, M. and Karikari, T. K. and Ashton, N. J. and Lantero Rodríguez, J. and Milà-Alomà, M. and Gispert, J. D. and Salvadó, G. and others},
  title   = {{Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected}},
  journal = {EMBO molecular medicine},
  year    = {2020},
  doi     = {10.15252/emmm.202012921},
  pmid    = {33169916},
  url     = {https://doi.org/10.15252/emmm.202012921}
}

@article{galasko2019-31853477,
  author  = {Galasko, D. and Xiao, M. and Xu, D. and Smirnov, D. and Salmon, D. P. and Dewit, N. and Vanbrabant, J. and Jacobs, D. and others},
  title   = {{Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2019},
  doi     = {10.1016/j.trci.2019.11.002},
  pmid    = {31853477},
  url     = {https://doi.org/10.1016/j.trci.2019.11.002}
}

@article{konijnenberg2021-33583080,
  author  = {Konijnenberg, E. and Tomassen, J. and den Braber, A. and Ten Kate, M. and Yaqub, M. and Mulder, S. D. and Nivard, M. G. and Vanderstichele, H. and others},
  title   = {{Onset of Preclinical Alzheimer Disease in Monozygotic Twins}},
  journal = {Annals of neurology},
  year    = {2021},
  doi     = {10.1002/ana.26048},
  pmid    = {33583080},
  url     = {https://doi.org/10.1002/ana.26048}
}

@article{hilal2018-29960604,
  author  = {Hilal, S. and Wolters, F. J. and Verbeek, M. M. and Vanderstichele, H. and Ikram, M. K. and Stoops, E. and Ikram, M. A. and Vernooij, M. W.},
  title   = {{Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study}},
  journal = {Alzheimer's research \& therapy},
  year    = {2018},
  doi     = {10.1186/s13195-018-0395-6},
  pmid    = {29960604},
  url     = {https://doi.org/10.1186/s13195-018-0395-6}
}

@article{gonzalez2025-39994784,
  author  = {González, Alba Cervantes and Goossens, Julie and Campuzano, E. Vera and Sala, Isabel and Sánchez‐Saudinós, María Belén and Rodríguez‐Baz, Íñigo and Lidón, Laia and Perlaza, Danna and others},
  title   = {{Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer’s pathophysiological biomarkers}},
  journal = {Alzheimer s Research \& Therapy},
  year    = {2025},
  doi     = {10.1186/s13195-025-01685-y},
  pmid    = {39994784},
  url     = {https://doi.org/10.1186/s13195-025-01685-y}
}

@article{fowler2022-36447478,
  author  = {Fowler, C. J. and Stoops, E. and Rainey-Smith, SR. and Vanmechelen, E. and Vanbrabant, J. and Dewit, N. and Mauroo, K. and Maruff, P. and others},
  title   = {{Plasma p-tau181/Aβ1-42 ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ1-42 and future cognitive decline}},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  year    = {2022},
  doi     = {10.1002/dad2.12375},
  pmid    = {36447478},
  url     = {https://doi.org/10.1002/dad2.12375}
}

@article{demeyer2025-40620474,
  author  = {De Meyer, Steffi and Alali, Soha and Laroy, Maarten and Casteele, Thomas Vande and Van Cauwenberge, Margot and Goossens, Julie and De Rocker, Charlotte and Vanbrabant, Jeroen and others},
  title   = {{Plasma vesicle-associated membrane protein 2 and glial fibrillary acidic protein associate with synaptic density in older adults without dementia}},
  journal = {Brain Communications},
  year    = {2025},
  doi     = {10.1093/braincomms/fcaf207},
  pmid    = {40620474},
  url     = {https://doi.org/10.1093/braincomms/fcaf207}
}

@article{gaetani2025-40405270,
  author  = {Gaetani, Lorenzo and Bellomo, Giovanni and Chiasserini, Davide and De Rocker, Charlotte and Goossens, Julie and Paoletti, Federico Paolini and Vanmechelen, Eugeen and Parnetti, Lucilla},
  title   = {{Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease}},
  journal = {Alzheimer s Research \& Therapy},
  year    = {2025},
  doi     = {10.1186/s13195-025-01762-2},
  pmid    = {40405270},
  url     = {https://doi.org/10.1186/s13195-025-01762-2}
}

@article{honey2025-41434517,
  author  = {Honey, Madison I. J. and Hok-A-Hin, Yanaika Sylvana and Thijssen, Elisabeth H. and van der Weijden, Babette and Stoops, Erik and de Boer, Sterre C.M. and Duits, Flora Hillegonde and van der Ende, Emma Louise and others},
  title   = {{CSF Acetylated Tau‐174 as a novel diagnostic and prognostic biomarker in Frontotemporal Dementia and Alzheimer’s Disease}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70861_108639},
  pmid    = {41434517},
  url     = {https://doi.org/10.1002/alz70861_108639}
}

@article{cline2025-39955261,
  author  = {Cline, Erika N. and Antwi‐Berko, Daniel and Sundell, Karen L. and Johnson, Elizabeth A. and Hyland, Maddelyn and Zhang, Hao and Vanderstichele, Hugo and Kaplow, June M. and others},
  title   = {{Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100082},
  pmid    = {39955261},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100082}
}

@article{vanbrabant2025-41518608,
  author  = {Vanbrabant, Jeroen and Van Loo, Maxime and Blancke, Nathan and Antwi‐Berko, Daniel and van der Flier, Wiesje M. and Verberk, Inge M.W. and Teunissen, Charlotte Elisabeth and Stoops, Erik},
  title   = {{Analytical Qualification of the BD‐Tau Xplorer kit on LUMIPULSE® G1200}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70856_105432},
  pmid    = {41518608},
  url     = {https://doi.org/10.1002/alz70856_105432}
}